339 related articles for article (PubMed ID: 35401554)
1. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
Front Immunol; 2022; 13():835630. PubMed ID: 35401554
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach.
Feng W; Li Y; Shen L; Zhang Q; Cai XW; Zhu ZF; Sun MH; Chen HQ; Fu XL
Ther Adv Med Oncol; 2021; 13():1758835920984975. PubMed ID: 33488784
[TBL] [Abstract][Full Text] [Related]
3. Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification.
Lin H; Pan X; Feng Z; Yan L; Hua J; Liang Y; Han C; Xu Z; Wang Y; Wu L; Cui Y; Huang X; Shi Z; Chen X; Chen X; Zhang Q; Liang C; Zhao K; Li Z; Liu Z
J Transl Med; 2022 Jun; 20(1):261. PubMed ID: 35672787
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a computed tomography-based immune ecosystem diversity index as an imaging biomarker in non-small cell lung cancer.
He L; Li ZH; Yan LX; Chen X; Sanduleanu S; Zhong WZ; Lambin P; Ye ZX; Sun YS; Liu YL; Qu JR; Wu L; Tu CL; Scrivener M; Pieters T; Coche E; Yang Q; Yang M; Liang CH; Huang YQ; Liu ZY
Eur Radiol; 2022 Dec; 32(12):8726-8736. PubMed ID: 35639145
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
6. A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy.
He L; Li Z; Chen X; Huang Y; Yan L; Liang C; Liu Z
Chin J Cancer Res; 2021 Oct; 33(5):592-605. PubMed ID: 34815633
[TBL] [Abstract][Full Text] [Related]
7. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of a 4-factor neoimmunologic score system in non-small cell lung cancer.
Yang F; Zeng Z; Li Y; Zhang D; Wei F; Zhao H; Zhang P; Ren X
J Leukoc Biol; 2022 Dec; 112(6):1605-1619. PubMed ID: 36073781
[TBL] [Abstract][Full Text] [Related]
9. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram Based on CT Deep Learning Signature: A Potential Tool for the Prediction of Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Lin T; Mai J; Yan M; Li Z; Quan X; Chen X
Cancer Manag Res; 2021; 13():2897-2906. PubMed ID: 33833572
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
14. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
15. Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study.
Wang Y; Pan X; Lin H; Han C; An Y; Qiu B; Feng Z; Huang X; Xu Z; Shi Z; Chen X; Li B; Yan L; Lu C; Li Z; Cui Y; Liu Z; Liu Z
J Transl Med; 2022 Dec; 20(1):595. PubMed ID: 36517832
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
Yang H; Wang K; Li S; Li Y; Yuan L
Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
[No Abstract] [Full Text] [Related]
17. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
18. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
Li J; Li X; Zhang C; Zhang C; Wang H
Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
[TBL] [Abstract][Full Text] [Related]
19. Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer.
Überall I; Gachechiladze M; Joerger M; Anděl J; Smičková P; Kolek V; Grygárková I; Škarda J
Lung Cancer; 2019 Mar; 129():85-91. PubMed ID: 30797498
[TBL] [Abstract][Full Text] [Related]
20. Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
Donnem T; Hald SM; Paulsen EE; Richardsen E; Al-Saad S; Kilvaer TK; Brustugun OT; Helland A; Lund-Iversen M; Poehl M; Olsen KE; Ditzel HJ; Hansen O; Al-Shibli K; Kiselev Y; Sandanger TM; Andersen S; Pezzella F; Bremnes RM; Busund LT
Clin Cancer Res; 2015 Jun; 21(11):2635-43. PubMed ID: 25680376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
